News

The WHO announced its plan to support GLP-1 weight-loss drugs, like Wegovy and Zepbound, to address the global obesity ...
Brigham Buhler, a MAHA influencer and biotech entrepreneur, has Robert F. Kennedy’s ear. But will RFK listen to his call to ...
Effective July 1, 2025, CVS Caremark will place Wegovy injection 2.4 mg as preferred on its commercial template formularies.
Eli Lilly's stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound. CVS Health said the drugs Wegovy and Saxenda from rival drugmaker Novo ...
President Donald Trump is under pressure to decide how widely available anti-obesity drugs should be and whether Medicare ...
Insurers reported 91 per cent increase in claims for weight-loss drugs last year after Wegovy launched in Canada ...
Taking Zepbound may help with weight loss when paired with exercise and ... talk with your insurance company or review your plan. Supply Chain and Shortages Drug manufacturers have sometimes ...
This comprehensive review of your health history and goals ensures that your weight loss plan, including any medications, such as Zepbound, is realistic and tailored to your needs. The program ...
In recent years, blockbuster glucagon-like peptide 1 receptor agonist (GLP-1RA) therapies like Eli Lilly’s Zepbound ...
Drugmaker Novo Nordisk NVO-N expects Wegovy weight-loss drug sales in the United States to start to recover once a ban on ...